Japanese Patent and Australia and New Zealand Trademarks for Accel‑Heal®
Published : 27/11/2015
We are delighted to announce that Accel‑Heal® Japanese patent application has now been granted. Accel‑Heal® has also been granted trademarks in Australia and New Zealand. These significant developments further expand Synapse's growing patent and trademark portfolios.
John Gildersleeve, Synapse Electroceutical's Chief Executive Officer said "We are very pleased with these latest grants which provide Accel‑Heal® with due protection along with the already granted TGA approval for Australia and New Zealand. We also look forward to working towards regulatory approval in Japan in due course, to make Accel‑Heal® available to patients and clinicians".
Please send your comments via Twitter